<div class="csl-bib-body">
<div class="csl-entry">Gerken, L. (2017). <i>Hafnia-basierte Nanopartikel zur Bildgebung und Therapie : Anpassung der physikalisch-chemischen Eigenschaften und Wechselwirkungen mit biologischen Entitäten : tailoring the physicochemical properties and itneractions with biological entities</i> [Diploma Thesis, Technische Universität Wien]. reposiTUm. https://doi.org/10.34726/hss.2017.43883</div>
</div>
-
dc.identifier.uri
https://doi.org/10.34726/hss.2017.43883
-
dc.identifier.uri
http://hdl.handle.net/20.500.12708/5247
-
dc.description.abstract
Cancer therapy remains a major global issue. While treatment modalities such as surgical resection, chemotherapy, radiotherapy, and thermal ablation have increased patient survival, resistance acquired in the course of the therapy eventually weaken the overall therapeutic success. In order to maximize treatment efficacy and minimize side effects, target cell selectivity is key. The therapy should be delivered exclusively to the tumor cells with minimal effects on healthy tissue. Various approaches have been developed to limit the radiation resistance while simultaneously enhancing the efficacy and safety of radiotherapy. Nanoparticles (NPs) hold promise as imaging probes and radiosensitizers in order to increase specificity. However, despite much excitement in the scientific community, translation of nanoparticle-based concepts has suffered from significant translational gaps, particularly in the field of biomedicine [23]. Among the nanomedicine-based products which have successfully been commercialized, the majority are based on liposomes. Other marketed nanomedicines include polymeric nanostructures and iron oxide nanoparticles [16, 30, 44]. Among the plethora of nanomaterials with feasible properties, hafnium dioxide has recently attracted attention due to the high dielectric constant ( = 25), high melting point (2758 °C), high atomic number (Z = 72), high density (9.7 g cm−3), high index of refraction, transparency to visible light (5.3–5.9 eV band gap), and chemical inertness. A HfO2 nanoparticle based formulation (NBTXR3, Nanobiotix) used as radiosensitizer has recently been submitted for market approval [44]. However, the understanding of the material properties, and especially its potential as a matrix for multimodal theranostic bioimaging combining x-ray imaging and radiosenzitation with lanthanide doped luminescence and MRI imaging, is vastly limited.
en
dc.language
English
-
dc.language.iso
en
-
dc.rights.uri
http://rightsstatements.org/vocab/InC/1.0/
-
dc.subject
Nanopartikel
de
dc.subject
Kontrastmittel
de
dc.subject
nanoparticles
en
dc.subject
contrast agents
en
dc.title
Hafnia-basierte Nanopartikel zur Bildgebung und Therapie : Anpassung der physikalisch-chemischen Eigenschaften und Wechselwirkungen mit biologischen Entitäten : tailoring the physicochemical properties and itneractions with biological entities
en
dc.title.alternative
Hafnia-based nanoparticles for imaging and therapy